Búsqueda
Utilizamos cookies para generar estadísticas que nos ayudan a mejorar la calidad de nuestro sitio web y su experiencia de usuario. Al hacer clic en «Aceptar todo», usted consiente el tratamiento de sus datos por parte de Acino y su transferencia a terceros. También puede personalizar su consentimiento para fines específicos de tratamiento de datos. Una vez que haya realizado su elección, haga clic en «Confirmar». Encontrará información detallada y podrá modificar sus preferencias en cualquier momento en nuestra Política de Privacidad .
Cookies necesarias Siempre activas
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Cookies analíticas
We would like to set Google Analytics cookies to help us analyse the traffic on our website.
ADQ plans to bolster its healthcare and pharma portfolio by acquiring Amoun Pharmaceutical Company
Arcera Life Sciences and Innogen Pharmaceuticals Sign Exclusive Licensing Agreement to Expand...
Agreement marks a significant step in Arcera’s strategy to strengthen its cardiometabolic franchise and broaden its portfolio of innovative medicines...
Arcera supports collective action to help prevent antimicrobial resistance
Arcera is joining the global effort to raise awareness of antimicrobial resistance (AMR) during World AMR Awareness Week 2026 (18–24...
Amoun, part of Arcera, marks World Heart Day 2026.
Promoting prevention, wellbeing, and community impact through awareness, education, and action. As part of Arcera’s global World Heart Day 2026...
The greatest investment the pharmaceutical industry can make is not in machines...
At AMOUN part of Arcera, we believe the future of pharmaceutical manufacturing starts with investing in the people who will...
Arcera Life Sciences reports progress on sustainability and responsible growth in 2025
Arcera Life Sciences announces the publication of its 2025 Sustainability Report, highlighting progress in embedding sustainability across its newly integrated...
Amoun – Part of Arcera Signs MoU with Egypt Healthcare Authority to...
In a step that underscores the growing importance of strategic collaboration in Egypt’s healthcare sector, Amoun – Part of Arcera has...
Arcera Life Sciences and Daewoong Expand Strategic Partnership to Bring Enavogliflozin to...
Expansion builds on successful collaboration across Latin America and reinforces commitment to advancing innovative cardiometabolic therapies across international markets.
From Market Access to Innovation: How Arcera Is Expanding the Pathway for...
Arcera provides medicines to patients across some of the world’s most dynamic and underserved healthcare markets. Through deep regulatory expertise, established commercial infrastructure, and a...
M42 and Arcera Partner to Advance Biopharma Localization and Next Generation Life...
Abu Dhabi, UAE – June 03, 2026: M42, a global health leader powered by technology, artificial intelligence, and genomics, and...
Acino, part of Arcera Recognized Among Ukraine’s Top Employers
Acino, part of Arcera in Ukraine has been named one of the Top 50 best employers in Ukraine and ranked...